Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    27-September-2000      
Issue 167 Next Update - 14:00 UTC 08:00 EST    28-September-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Back To Vidyya Early Treatment With Interferon Beta-1a May Delay Onset Of MS

Trial Results May Change Current Treatment Approach For MS

Individuals determined to be "at risk" for Multiple Sclerosis (MS) found themselves on the receiving end of some good news yesterday. A groundbreaking new study published in the New England Journal of Medicine has demonstrated that early drug treatment can significantly delay the onset of multiple sclerosis (MS). The study's authors believe the research could result in a fundamental change in treatment for MS.

The NEJM study found that early treatment with interferon beta-1a (Avonex ®) reduced the rate of development of MS by over 44 percent versus treatment with placebo. The multi-center trial followed 383 people who had one symptom of MS but were not yet diagnosed with the disease. An additional positive note found in the study was that patients in the treament group experienced a relative reduction in the number and volume of brain lesions viewed through MRI scans.

The trial was halted early when it bacame apparent that the positive results were so overwhelming. The patients in the placebo group were offered the benefits of treatment.

Multiple sclerosis is a chronic disease of the central nervous system that affects approximately 400,000 Americans and about one million individuals worldwide. Over 200 new cases are diagnosed each week. Until now, there have been no guidelines for treating individuals who appear at risk of developing MS.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.